Outcomes in Rotator Cuff Repair Using Graft Reinforcement
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.
| Condition | Intervention |
|---|---|
|
Rotator Cuff Tear |
Device: Conexa Reconstructive Tissue Matrix |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective, Multi-Center, Single-Arm Study to Assess Clinical Outcomes In Primary Open or Mini-Open Rotator Cuff Repair Using Conexa Graft Reinforcement |
- Validated shoulder specific outcome measure [ Time Frame: baseline, post-op months 3, 6, 12, and 24 ] [ Designated as safety issue: No ]
The following shoulder surveys will be employed:
- American Shoulder and Elbow Score (ASES)
- Constant-Murley Score (not completed at post-op month 3)
- Simple Shoulder Test (SST)
- Rotator Cuff Re-tear evaluation [ Time Frame: Post-op months 6 and 12 ] [ Designated as safety issue: No ]Subjects will have MRI to assess healing of the repaired tendon at 6 and 12 months post-op. The rate of re-tear will be reported.
- Safety [ Time Frame: All time points ] [ Designated as safety issue: Yes ]
The following safety information will be reported:
- related adverse events
- Infection (incision; wound, surgical site)
- Seroma
- Hematoma
- Inflammation (surgical site, wound)
| Enrollment: | 61 |
| Study Start Date: | October 2009 |
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Conexa Reconstructive Tissue Matrix
Conexa will be placed as a soft tissue reinforcement at the rotator cuff repair site
|
Device: Conexa Reconstructive Tissue Matrix
Conexa will be placed as a soft tissue reinforcement in primary open or mini-open rotator cuff repair procedures
Other Name: Conexa, Conexa TM
|
Detailed Description:
Conexa is a surgical mesh derived from porcine dermis and processed to produce an acellular dermal matrix. It is designed to perform as a surgical mesh for use as a soft tissue patch to reinforce soft tissue where weaknesses exist and for the surgical repair of damaged or ruptured soft tissue membranes. The purpose of this post-market clinical study is to collect safety and efficacy data when Conexa is used to repair torn tendons of the rotator cuff. Conexa will be used in accordance with its labeling for this clinical study.
Eligibility| Ages Eligible for Study: | 40 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
The patient:
- is an adult male or female between the ages of 40-70 years old;
- has repairable primary large retracted two-tendon rotator cuff tears measuring from 3 cm to 5 cm;
- requires surgical repair of single rotator cuff (i.e. one limb);
- has movement of the non-operative arm defined as shoulder elevation of equal to or greater than 90 degrees and is able to perform postoperative exercises;
- is able to return for all scheduled and required study visits;
- is able to provide written informed consent for study participation.
Exclusion Criteria:
The patient:
- has irreparable large rotator cuff tears that are found intra-operatively. Note: irreparable is defined by the inability to approximate the tendon to the tuberosity without tension;
- has a rotator cuff tear < 3cm (measured intra-operatively);
- has a rotator cuff tear > 5cm (measured intra-operatively);
- has a rotator cuff tear where the subscapularis tendon is disrupted/requires repair;
- has grade 3 or 4 fatty infiltration of the rotator cuff;
- has had prior surgical repair to the affected shoulder;
- is American Society of Anesthesiologists (ASA) Class 4 or 5 (See Appendix I);
- is a tobacco user; unless tobacco free 6 months prior to surgery and willing to remain tobacco free for the duration of the study.
- has lower limb injuries requiring walking assist devices such as crutches and walkers;
- has a known collagen disorder, including systemic lupus erythematous (SLE), rheumatoid arthritis (RA), polymyositis, scleroderma, ankylosing spondylitis, dermatomyositis, osteogenesis imperfecta or the inherited disorders of Sjogren, Larsen, Raynaud, Ehlers-Danlos or Marfan syndrome.
- has obstacles that pose an inordinately high surgical risk, in the judgment of the certified surgeon;
- has co-morbid factors which predispose to postoperative infection, such as insulin dependent diabetes, chronic steroid use, malnourishment, cancer, or co-existent infection;
- has a history of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction;
- is enrolled or plans to enroll in another clinical trial during this study that would affect the patient's safety or results of this trial;
- has any of the conditions identified within the labeled contraindications, i.e. sensitivity to porcine derived products or polysorbate.
- has an inability to have a closed MRI conducted.
- needs a re-operation for a re-tear of the rotator cuff.
Contacts and Locations| United States, Arizona | |
| Orthopaedic Clinical Association | |
| Phoenix, Arizona, United States, 85016 | |
| United States, Illinois | |
| Rush University Medical Center | |
| Chicago, Illinois, United States, 60612 | |
| United States, North Carolina | |
| Duke University Medical Center | |
| Durham, North Carolina, United States, 27710 | |
| United States, Ohio | |
| OrthoNeuro | |
| New Albany, Ohio, United States, 43054 | |
| United States, Pennsylvania | |
| Rotheman Institute | |
| Philadelphia, Pennsylvania, United States, 19107 | |
| United States, West Virginia | |
| West Virginia University | |
| Morgantown, West Virginia, United States, 26506 | |
| Study Director: | Joseph Iannotti, MD | Cleveland, OH |
| Study Director: | John Sperling, MD | Rochester, MN |
More Information
No publications provided
| Responsible Party: | Tornier |
| ClinicalTrials.gov Identifier: | NCT01025037 History of Changes |
| Other Study ID Numbers: | Tornier-LIFC LFC2008.03.02 |
| Study First Received: | December 1, 2009 |
| Last Updated: | January 24, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Tornier:
|
Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear |
ClinicalTrials.gov processed this record on May 21, 2013